I notice with interest that som has been described by our ceo as being well positioned regardless of delay[approx 4 months] in medicare approvals for dentists wanting to specialise in sleep medicine in north america.
Quite obviously ceo is confident of expansion especially given 2 new vice presidents.
My querie is about whether the ceo's concern with medicare is about the authority or approval to operate as a sleep dentist or is it a concern about whether a rebate will be paid on devices fitted. The answer is probably in news past but an easy answer may be available in this forum.
medicare approvals
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $74.55M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.5¢ | 34.5¢ | $2.453K | 7.109K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7999 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 75000 | 1 |
View Market Depth
| Last trade - 15.49pm 25/07/2024 (20 minute delay) ? |
| SOM (ASX) Chart |